|
Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 44-47
|
Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
PACLITAXEL;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
BREAST METASTASIS;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUCOVORIN;
MIDDLE AGED;
NEUTROPENIA;
PACLITAXEL;
REMISSION INDUCTION;
|
EID: 0029922955
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (0)
|